Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle? Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Breast Neoplasms
  • Diagnostic Errors
  • Sentinel Lymph Node Biopsy
  • Specimen Handling

abstract

  • Our results indicate that nearly half of patients with breast cancer with a P/LP variant with clinically actionable and/or management guidelines in development are missed by current testing guidelines. We recommend that all patients with a diagnosis of breast cancer undergo expanded panel testing.

publication date

  • February 20, 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.18.01631

PubMed ID

  • 30526229

Additional Document Info

start page

  • 453

end page

  • 460

volume

  • 37

number

  • 6